BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28085741)

  • 1. The Behavior Rating Inventory of Executive Function (BRIEF) to Identify Pediatric Acute Lymphoblastic Leukemia (ALL) Survivors At Risk for Neurocognitive Impairment.
    Viola A; Balsamo L; Neglia JP; Brouwers P; Ma X; Kadan-Lottick NS
    J Pediatr Hematol Oncol; 2017 Apr; 39(3):174-178. PubMed ID: 28085741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of sleep, fatigue, and systemic inflammation on neurocognitive and behavioral outcomes in long-term survivors of childhood acute lymphoblastic leukemia.
    Cheung YT; Brinkman TM; Mulrooney DA; Mzayek Y; Liu W; Banerjee P; Panoskaltsis-Mortari A; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Cancer; 2017 Sep; 123(17):3410-3419. PubMed ID: 28452142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing neurocognitive late effects in childhood leukemia survivors using a combination of neuropsychological and cognitive neuroscience measures.
    Van Der Plas E; Erdman L; Nieman BJ; Weksberg R; Butcher DT; O'connor DL; Aufreiter S; Hitzler J; Guger SL; Schachar RJ; Ito S; Spiegler BJ
    Child Neuropsychol; 2018 Nov; 24(8):999-1014. PubMed ID: 29017430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of neurocognitive function in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.
    Liu W; Cheung YT; Conklin HM; Jacola LM; Srivastava D; Nolan VG; Zhang H; Gurney JG; Huang IC; Robison LL; Pui CH; Hudson MM; Krull KR
    J Cancer Surviv; 2018 Jun; 12(3):398-406. PubMed ID: 29484542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study.
    Adler LA; Dirks B; Deas PF; Raychaudhuri A; Dauphin MR; Lasser RA; Weisler RH
    J Clin Psychiatry; 2013 Jul; 74(7):694-702. PubMed ID: 23945447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parent-reported executive function behaviors and clinician ratings of attention-deficit/hyperactivity disorder symptoms in children treated with lisdexamfetamine dimesylate.
    Findling RL; Adeyi B; Dirks B; Babcock T; Scheckner B; Lasser R; DeLeon A; Ginsberg LD
    J Child Adolesc Psychopharmacol; 2013 Feb; 23(1):28-35. PubMed ID: 23410139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Executive function late effects in survivors of pediatric brain tumors and acute lymphoblastic leukemia.
    Winter AL; Conklin HM; Tyc VL; Stancel H; Hinds PS; Hudson MM; Kahalley LS
    J Clin Exp Neuropsychol; 2014; 36(8):818-30. PubMed ID: 25126830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Everyday executive function in standard-risk acute lymphoblastic leukemia survivors.
    Walsh KS; Paltin I; Gioia GA; Isquith P; Kadan-Lottick NS; Neglia JP; Brouwers P
    Child Neuropsychol; 2015; 21(1):78-89. PubMed ID: 24428397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validating the Behavior Rating Inventory of Executive Functioning for Children With ADHD and Their Typically Developing Peers.
    Davidson F; Cherry K; Corkum P
    Appl Neuropsychol Child; 2016; 5(2):127-37. PubMed ID: 26110907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of child executive functions to parenting capacities in childhood acute lymphoblastic leukemia survivors.
    Sharkey CM; Clawson AH; Mullins LL; Brinkman TM; Pui CH; Hudson MM; Krull KR
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27761. PubMed ID: 31033172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auditory attention late effects in pediatric acute lymphoblastic leukemia.
    Holland AA; Clem MA; Lampson E; Stavinoha PL
    Child Neuropsychol; 2020 Oct; 26(7):865-880. PubMed ID: 32475222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy Pharmacodynamics and Neuroimaging and Neurocognitive Outcomes in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia.
    Krull KR; Cheung YT; Liu W; Fellah S; Reddick WE; Brinkman TM; Kimberg C; Ogg R; Srivastava D; Pui CH; Robison LL; Hudson MM
    J Clin Oncol; 2016 Aug; 34(22):2644-53. PubMed ID: 27269941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone deficiency and neurocognitive function in adult survivors of childhood acute lymphoblastic leukemia.
    Krull KR; Li C; Phillips NS; Cheung YT; Brinkman TM; Wilson CL; Armstrong GT; Khan RB; Merchant TE; Sabin ND; Srivastava D; Pui CH; Robison LL; Hudson MM; Sklar CA; Chemaitilly W
    Cancer; 2019 May; 125(10):1748-1755. PubMed ID: 30690723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suicidal ideation and executive functioning in pediatric cancer.
    Sharkey CM; Hardy KK; Gioia A; Weisman H; Walsh K
    Psychooncology; 2022 May; 31(5):745-752. PubMed ID: 34797956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health Related Quality of Life and Neurocognitive Outcomes in the First Year after Pediatric Acute Liver Failure.
    Sorensen LG; Neighbors K; Hardison RM; Loomes KM; Varni JW; Ng VL; Squires RH; Alonso EM;
    J Pediatr; 2018 May; 196():129-138.e3. PubMed ID: 29551316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-sectional follow-up study of physical morbidities, neurocognitive function, and attention problems in post-treatment childhood acute lymphoblastic leukemia survivors.
    Chiou SS; Lin PC; Liao YM; Yang P
    Kaohsiung J Med Sci; 2019 Jun; 35(6):373-378. PubMed ID: 30913362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward Operationalizing Executive Function Deficits in Adults With ADHD Using the Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A).
    Biederman J; DiSalvo ML; Hutt Vater CR; Woodworth KY; Faraone SV
    J Clin Psychiatry; 2022 Nov; 84(1):. PubMed ID: 36416743
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurocognitive Outcome in Very Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia After Treatment with Chemotherapy Only.
    Kanellopoulos A; Andersson S; Zeller B; Tamnes CK; Fjell AM; Walhovd KB; Westlye LT; Fosså SD; Ruud E
    Pediatr Blood Cancer; 2016 Jan; 63(1):133-8. PubMed ID: 26312396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of the Behavior Rating Inventory of Executive Function - Preschool version (BRIEF-P) in young children with epilepsy.
    Maiman M; Salinas CM; Gindlesperger MF; Westerveld M; Vasserman M; MacAllister WS
    Child Neuropsychol; 2018 Oct; 24(7):975-985. PubMed ID: 28849706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.